The investigators use mindfulness-based cognitive therapy (MBCT) on patients who have never previously practiced the technique, with the aim of possibly re-training their brains to remove their static-type images.

A multicenter study in Japan examined patients to understand geographic atrophy characteristics and progression rate.

According to the companies, the merger creates a NASDAQ-listed, late clinical-stage biopharmaceutical company focused on advancing LENZ Therapeutics’ lead assets for the treatment of presbyopia.

The grant donated by Russell Wilson and Ciara will be used in the efforts to help underprivileged, visually-impaired children.

Real-time insights into fluctuations enhance glaucoma care and understanding of vision risk.

Catch up on what happened in optometry during the week of November 13-November 17.

Using the NEI protocol for addressing corneal staining, researchers used 5 microliters of 2%, non preserved fluorescein and then evaluated corneal staining.

This is just one of many times the FDA has issued a warning to companies for the sale of unapproved ophthalmic products in 2023.

Hear about the new innovations on the market—and coming soon—from Alcon.

Is telemedicine through retinal images a solution to earlier intervention and increased access to care? Fortunately—and unfortunately—yes.

ONE by ONE and Biotrue Eye Care Recycling programs from Bausch + Lomb have collected over 464,100 pounds of used contact lens materials that would have otherwise been sent to a landfill.

A rapid-fire, top-level review of what happened in optometry in 2023.

Counsel your at-risk patients on strategies to minimize severe hypoglycemia.

Hear how this daily disposable silicone hydrogel option fits patients' busy and active lifestyles.

Even if DLS is completely normal and expected, it can be mentally and emotionally difficult for patients.